| Literature DB >> 22524430 |
Carmela R Balistreri1, Giuseppina Candore, Giulia Accardi, Manuela Bova, Silvio Buffa, Matteo Bulati, Giusi I Forte, Florinda Listì, Adriana Martorana, Marisa Palmeri, Mariavaleria Pellicanò, Loredana Vaccarino, Letizia Scola, Domenico Lio, Giuseppina Colonna-Romano.
Abstract
The demographic and social changes of the past decades have determined improvements in public health and longevity. So, the number of centenarians is increasing as a worldwide phenomenon. Scientists have focused their attention on centenarians as optimal model to address the biological mechanisms of "successful and unsuccessful ageing". They are equipped to reach the extreme limits of human life span and, most importantly, to show relatively good health, being able to perform their routine daily life and to escape fatal age-related diseases, such as cardiovascular diseases and cancer. Thus, particular attention has been centered on their genetic background and immune system. In this review, we report our data gathered for over 10 years in Sicilian centenarians. Based on results obtained, we suggest longevity as the result of an optimal performance of immune system and an over-expression of anti-inflammatory sequence variants of immune/inflammatory genes. However, as well known, genetic, epigenetic, stochastic and environmental factors seem to have a crucial role in ageing and longevity. Epigenetics is associated with ageing, as demonstrated in many studies. In particular, ageing is associated with a global loss of methylation state. Thus, the aim of future studies will be to analyze the weight of epigenetic changes in ageing and longevity.Entities:
Year: 2012 PMID: 22524430 PMCID: PMC3402998 DOI: 10.1186/1742-4933-9-8
Source DB: PubMed Journal: Immun Ageing ISSN: 1742-4933 Impact factor: 6.400
Main modifications of B cells and B cells products in elderly human observed in our laboratory
| B cells or B cells products | Changes | References |
|---|---|---|
| Total B cells (percentage) | ↓ | [ |
| CD19+CD5+ B1 cells (percentage and absolute number) | ↓ | [ |
| IgG, IgA | ↑ | [ |
| IgM, IgD | ↓ | [ |
| IgE | = | [ |
| Autoantibodies | ↑ | [ |
| Naive (IgD+CD27-) | ↓ | [ |
| DN (IgD-CD27-) | ↑ | [ |
Cellular and humoral immune modification in offspring from longevity families compared to their AM controls
| T and B cell Phenotypes and Products | Changes | References |
|---|---|---|
| Naïve T cells (CD3+CD8+CD45RA+CCR7+CD27+CD28+) | Increase | [ |
| Late differentiated effector memory T cells (CD3+CD8+CD45RA-CCR7-CD27-CD28-) | Decrease | [ |
| TEMRA (CD3+CD8+CD45RA+CCR7-CD27-CD28-) | Decrease | [ |
| Naïve B cells (IgD+CD27-) | Increase | [ |
| Double Negative B cells (IgG+/IgA+IgD-CD27-) | Decrease | [ |
| Serum IgM | Increase | [ |
Data from our investigations in Sicilian population
| N = 35 females | N = 106 females | ||||
| HFE | C282 | 47 (84%) | 132 (0%) | 8.3 × 10-5 [ | |
| 282Y | 9 (16%) | 0 (0%) | |||
| N = 55 males | N = 127 males | N = 105 males | |||
| TLR4 | +896A | 94 (85.4%) | 239 (94.1%) | 205 (97.6%) | < 0.001 [ |
| +896 G | 16 (14.6%) | 15 (5.9%) | 5 (2.4%) | ||
| N = 123 males | N = 136 males | N = 133 males | |||
| CCR5 | WT | 221(89.8%) | 252 (92.6%) | 263 (98.8%) | 0.00006 [ |
| Δ32 | 25 (10.2%) | 20 (7.4%) | 3 (1.2%) | ||
| N = 96 males | N = 170 males | N = 140 males | |||
| Cox-2 | -765 G | 122 (63.5%) | 240 (70.6%) | 232(82.8%) | 0.000007 [ |
| -765 C | 70(36.5%) | 100(29.4%) | 48(17.2%) | ||
| 5-Lo | -1708 G | 180 (93.7%) | 302(88.8%) | 224(80%) | 0.00003 [ |
| -1708A | 12(6.3%) | 38(11.2%) | 56(20%) | 0.001 | |
| 21 C | 176(91.7%) | 299(88%) | 225(80.4%) | ||
| 21 T | 16(8.3%) | 41(12%) | 55(19.6%) | ||
| N = 55 males | N = 125 males | N = 50 males | |||
| TLR4 | +896A | 94 (85%) | 235 (94%) | 99 (99%) | 0.001 [ |
| +896 G | 16 (15%) | 15 (6%) | 1 (1%) | ||
| Cox-2 | -765 G | 67 (61%) | 176 (70%) | 77 (77%) | 0.05 |
| 5-Lo | -765 C | 43 (39%) | 74 (30%) | 23(23%) | 0.0007 |
| -1708 G | 104 (95%) | 223 (89%) | 77 (77%) | ||
| -1708A | 6 (5%) | 27 (11%) | 23 (23%) | ||
| N = 53 males | N = 50 males | ||||
| CCR5 | WT | 95 (89.6%) | 97 (97%) | 0.03 [ | |
| Δ32 | 11(10.4%) | 3(3%) | |||
| N = 42 females | N = 42 females | N = 42 females | |||
| TLR4 | +896A | 81 (96.4%) | 78 (92.9%) | 76 (90.4%) | 0.003 [ |
| + 896 G | 3 (3.6%) | 6 (7.1%) | 8 (9.6%) | ||
Cytokine data from our studies in Sicilian population
| N = 31 males | N = 161 males | ||||
| IL-10 | -1082GG | 18 (58%) | 55 (34%) | < 0.025 [ | |
| -1083GA | 9 (29%) | 88 (55%) | |||
| -1082AA | 4 (13%) | 18 (11%) | |||
| N = 72 males | N = 115 males | ||||
| IL-10 | -1082GG | 33 (46%) | 32(28%) | 0.019 [ | |
| -1083GA | 34(47%) | 64(56%) | |||
| -1082AA | 5(7%) | 19(16%) | |||
| N = 52 males | N = 110 males | N = 90 males | |||
| IL-10 | -1082GG | 25 (48.1%) | 26(23.6%) | 17 (18.9%) | 0.003 [ |
| -1083GA | 23 (44.2%) | 56 (50.9%) | 29 (32.2%) | ||
| -1082AA | 6(11.5%) | 28 (25.5%) | 44 (48.9%) | ||
| P | |||||
| N = 142 females | N = 90 females | ||||
| IFN-γ | +874 T | 102 (35.9%) | 85 (47.2%) | 0.02 [ | |
| + 874A | 182 (64.1%) | 95 (52.8%) | |||